Drug Information

Drug General Information
Drug ID
D00AHD
Former ID
DNC007781
Drug Name
Anthracen-10-yl(10H-phenothiazin-10-yl)methanone
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528978]
Formula
C27H17NOS
Canonical SMILES
C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C(=O)N4C5=CC=CC=C5SC6=CC=C<br />C=C64
InChI
1S/C27H17NOS/c29-27(26-20-11-3-1-9-18(20)17-19-10-2-4-12-21(19)26)28-22-13-5-7-15-24(22)30-25-16-8-6-14-23(25)28/h1-17H
InChIKey
GEDDVJWUHICGPI-UHFFFAOYSA-N
PubChem Compound ID
44435223
Target and Pathway
Target(s) Cholinesterase Target Info Inhibitor [528978]
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
WikiPathways Irinotecan Pathway
References
Ref 528978Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. Epub 2007 Jul 6.Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.
Ref 528978Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. Epub 2007 Jul 6.Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.